Galovic, Marian;
(2021)
Measuring NMDA receptors in vivo using [¹⁸F]GE-179 PET in health and disease.
Doctoral thesis (Ph.D), UCL (University College London).
Preview |
Text
Galovic_PhD_Thesis.pdf Download (9MB) | Preview |
Abstract
Background: N-methyl-D-aspartate receptors (NMDAR) are important glutamatergic ion channels in the brain. Studying the functional activation of NMDAR in vivo in humans has not been possible until recently. / Methods: We used positron emission tomography (PET) with [18F]GE-179, a novel radioligand binding inside the open NMDAR channel, to assess the in vivo activation of NMDAR. We developed methodology for quantification of ligand binding (Project 1) that did not require arterial sampling and was then applied to study NMDAR activation in aging (n=29, Project 2), epilepsy (n=26, Project 3), and Anti-NMDAR encephalitis (n=5, Project 4). / Results: In Project 1, we validated a method for kinetic modelling using an imagederived input function and serial venous samples. This approach provided unbiased estimates of ligand volume of distribution (VT) that were highly correlated (r=0.95, p<0.001) with the gold standard, an arterial input function. In Project 2, we observed increased tracer uptake related to aging in healthy individuals (VT increase of 0.6 per 10 years, p=0.04), particularly in bilateral hippocampi, temporo-parieto-occipital junctions, dorsolateral prefrontal cortex, and striata. In people with epilepsy, the age-related increase in VT (1.4 per 10 years, p=0.006) was most pronounced in the striatum and thalamus. In Project 3, we found reduced interictal ligand uptake in epilepsy that was related to longer disease duration (VT decrease of 1.6 per 10 years, p=0.004), spatially widespread and bihemispheric. Regional uptake was increased in those taking lacosamide and after anterior temporal lobe resection. In Project 4, we observed decreased ligand uptake in Anti-NMDAR encephalitis with persisting Anti-GluN1-antibodies (mean VT 6.2 in cases vs. 8.8 in healthy volunteers, p=0.02), particularly in bilateral anterior temporal and superior parietal lobes. / Conclusions: [18F]GE-179 PET is useful to detect altered NMDAR function. We observed increased NMDAR activation in aging and decreased activation in interictal epilepsy and antibody-positive Anti-NMDAR encephalitis.
Type: | Thesis (Doctoral) |
---|---|
Qualification: | Ph.D |
Title: | Measuring NMDA receptors in vivo using [¹⁸F]GE-179 PET in health and disease |
Event: | UCL (University College London) |
Open access status: | An open access version is available from UCL Discovery |
Language: | English |
Additional information: | Copyright © The Author 2021. Original content in this thesis is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) Licence (https://creativecommons.org/licenses/by-nc/4.0/). Any third-party copyright material present remains the property of its respective owner(s) and is licensed under its existing terms. Access may initially be restricted at the author’s request. |
UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL |
URI: | https://discovery.ucl.ac.uk/id/eprint/10139291 |
Archive Staff Only
View Item |